EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN THE NORTH-WEST REGION OF RUSSIA (RESULTS OF A OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2)
DOI:
https://doi.org/10.21638/11701/spbu11.2017.201Abstract
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important problem that can lead to cirrhosis and hepatic failure. It may be the most prevalent liver disease. However,knowledge of the epidemiology is limited. These findings encourage to conduct a larger sample size study to evaluate the real prevalence of NAFLD in the Russian population. It is important to know current prevalence of NAFLD. DIREG 2 study was performed under umbrella of leading Russian professional societies in partnership with Sanofi Russia. Objective: to estimate the prevalence of NAFLD within the general practitioner’s and gastroenterologist’s patient flow. It is important to know current prevalence of NAFLD in North-West region and to compare with DIREG 2 results. Materials and methods.
Epidemiologic, observational, multicenter study assessing the prevalence of NAFLD among patients outpatient practice. A total of 50 145 patients (3769 in North-West region) including those suspected of having NAFLD criteria were enrolled in the Program. The investigators were qualified doctors (GPs \ therapist’s \ gastroenterologists), providing outpatient care for the population. The epidemiological data were obtained, recorded during two routine patient visits to investigating centers. Study results. Percentage of patients with revealed NAFLD within the patient flow primary or consistently coming to selected doctors for any reason including those suspected of having NAFLD was 37,3 % in Russia vs 49,1 % in North West Region. Conclusion. Prevalence of NAFLD among patient flow of doctors in Russia is quite high. It has been revealed a high prevalence of NANCFLD within the patient flow primary or consistently coming to selected by doctors for any reason. Refs 55. Figs 4. Table 1.
Keywords:
DIREG 2, epidemiology, NAFLD, non-alcoholic fatty liver disease, NASH, nonalcoholic steatohepatitis, prevalence
Downloads
References
DIREG 2 // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015. № 6.С. 31–41.
liver disease. URL: http://www.journal-of-hepatology.eu/article/S0168-8278(15)00734-5/pdf (дата обращения 23.09.2016).
References
double-blind trial on «essential» phospholipids in the treatment of fatty liver associated with diabetes. Med.
Chir. Digest., 1988, vol. 17, pp. 61–85.
cardiovascular disease . World J. Gastroenterol, 2007, vol. 13, pp. 1579–1584.
levels. Hepatology, 2009, vol. 50, pp. 1403–1411.
fatty liver disease and mortality among US adults: prospective cohort study. BMJ. 2011, vol. 343.
d6891.
Malnick S. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic
and tissue Doppler imaging assessment. Journal of clinical gastroenterology, 2006, vol. 40, no. 10,
pp. 949–955.
of diagnosis and treatment]. Profilaktika zabolevanii i ukreplenie zdorov’ia [Disease prevention and health promotion], 2005, vol. 8, no. 6, pp. 41–45. (In Russian)
alcoholic liver disease in the stage of steatosis and hepatitis drugs and Essliver Forte Essentiale Forte N]. Farmakoekonomika. Sovremennaia farmakoekonomika i farmakoepidemiologiia [Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology], 2009, no. 1, pp. 7–11. (In Russian)
pecheni v Rossii [Epidemiological features of nonalcoholic fatty liver disease in Russia]. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii [Russian J. gastroenterology, hepatology and coloproctology] , 2014, no. 4, pp. 32–38. (In Russian)
E. V., Vasiutin A. V. Nealkogol’naia zhirovaia bolezn’ pecheni u vzroslogo gorodskogo naseleniia Rossii
(Rasprostranennost’ i faktory riska) [Nonalcoholic fatty liver disease in the adult urban population of Russia
(Prevalence and risk factors)]. Vrach [Doctor], 2010, no. 9, pp. 1–4. (In Russian)
V. V., Ushakova T. I. Rasprostranennost’ nealkogol’noi zhirovoi bolezni pecheni u patsientov ambulatorno-
poliklinicheskoi praktiki v Rossiiskoi Federatsii: rezul’taty issledovaniia DIREG 2 [Non-alcoholic fatty liver disease prevalence among patient’s outpatient practice of the Russian Federation: DIREG 2 study results]. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii [Russian J. gastroenterology, hepatology and coloproctology], 2015, no. 6, pp. 31–41. (In Russian)
syndrome: an American Heart Association / National Heart, Lung, and Blood Institute Scientific Statement.
Circulation, 2005, vol. 112 (17), pp. 2735–2752.
S. M., Hobbs H. H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 2004, vol. 40 (7), pp. 1387–1395.
general population of Okinawa, Japan. Jap. J. Med., 1998, vol. 27 (1), pp. 142–149.
due to non-alcoholic steatohepatitis and hepatitis C. Hepatology, 2006, vol. 43, pp. 682–689.
development of standard cost of illness methodology for the health technology assessment]. Farmakoekonomika. Sovremennaia farmakoekonomika i farmakoepidemiologiia [Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology], 2014, no. 3, pp. 3–11. (In Russian)
Shul’pekova Iu. O., Tsukanov V. V., Mammaev S. N., Maev I. V., Pal’gova L. K., Tikhonov I. N. Klinicheskie
rekomendatsii po diagnostike i lecheniiu nealkogol’noi zhirovoi bolezni pecheni Rossiiskogo obshchestva
po izucheniiu pecheni i Rossiiskoi gastroenterologicheskoi assotsiatsii [Clinical guidelines for the diagnosis
and treatment of non-alcoholic fatty liver disease, the Russian Society for the Liver Study and the Russian
Gastroenterological Association]. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii [Russian
J. gastroenterology, hepatology and coloproctology], 2016, no. 2, pp. 24–42. Available at: http://www.gastro-j.ru/files/24_42_1461884541.pdf (accessed: 17.08.2016). (In Russian)
zabolevaniia [Neuro-immune mechanism of epilepsy as a key to pathogenetic treatment of the disease]. Epilepsiia i paroksizmal’nye sostoianiia [Epilepsy and Paroxismal Conditions],2010, no. 2 (3), pp. 20-27. (In Russian)
Blinov D. V., Shirokova E. N., Tsukanov V. V. Non-alcoholic fatty liver disease risk factor sassessment among
the general practitioners and gastroenterologist’s patients flow. United European Gastroenterology Journal,2015, vol. 3 (1), pp. 344–345.
from soybean in liver diseases. Pharmacol. Rep., 2011, vol. 63, pp. 643–659.
neither? Hepatology, 2008, vol. 48, no. 2, pp. 662–669.
Sravnitel’noe izuchenie gepatoprotektornykh preparatov Essentsiale Forte N, Fosfogliv, Essliver Forte
[Comparative study of hepatoprotective drugs Essentiale Forte N, Phosphogliv, Essliver Forte]. RMZh. Gastroenterologiia [RMJ. Gastroenterology], 2013, no. 13. (In Russian)
(In Russian)
vitamin B complex in the treatment of patients with disorders of the hepatobiliary function caused by unbalanced nutrition. Clin. Ter., 1989, vol. 131 (4), pp. 237–246.
techeniia beremennosti u zhenshchin pri stetoze pecheni i ozhirenii [Peculiarities of pregnancy in women
with liver steatosis and obesity]. Zhurnal akusherstva i zhenskikh boleznei [Journal of Obstetrics and
Women’s Diseases], 2013, vol. LXII, issue 6, pp. 47–54. (In Russian)
Downloads
Published
How to Cite
Issue
Section
License
Articles of "Vestnik of Saint Petersburg University. Medicine" are open access distributed under the terms of the License Agreement with Saint Petersburg State University, which permits to the authors unrestricted distribution and self-archiving free of charge.